FITC Anti-Human CD11a Antibody[TS1/22.1.1.13]

FITC Anti-Human CD11a Antibody[TS1/22.1.1.13]

The FITC Anti-Human CD11a Antibody [TS1/22.1.1.13] is a highly specific and reliable tool designed for the detection and analysis of CD11a, a cell surface glycoprotein expressed on human leukocytes. This antibody is conjugated with FITC (fluorescein isothiocyanate), a fluorescent dye that allows for easy visualization and identification of CD11a-positive cells using flow cytometry or fluorescence microscopy techniques.

The TS1/22.1.1.13 antibody is derived from a hybridoma cell line and has been extensively characterized for its specificity and performance. It recognizes the alpha subunit of the CD11a/CD18 heterodimer, also known as LFA-1 (lymphocyte function-associated antigen-1). LFA-1 plays a crucial role in leukocyte adhesion and migration, making it an important marker for immune cell activation and inflammation.

This FITC-conjugated antibody offers several advantages for researchers in the field of immunology and cell biology. Its bright and stable fluorescence signal allows for accurate and sensitive detection of CD11a expression levels on various cell types, including T cells, B cells, monocytes, and granulocytes. The high specificity of the TS1/22.1.1.13 antibody ensures minimal background staining, enabling precise identification and isolation of CD11a-positive cells. With its excellent performance and versatility, this antibody is an invaluable tool for studying immune responses, leukocyte trafficking, and inflammatory processes in both research and clinical settings.